CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Mateon Therapeutics Inc's Tangible Leverage Ratio

OXGN's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




OXGN Tangible Leverage Ratio (Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
(Sep 30 2017)
III. Quarter
Y / Y Tangible Equity Change -96.71 % -89.46 % - - -90.62 %
Y / Y Total Liabilities Change -12.11 % 9.81 % 7.74 % -26.45 % -18.68 %
Tangible Leverage Ratio MRQ 17.02 2.66 - - 0.64
Overall Ranking # # # # #
Seq. Tangible Equity Change -89.22 % - - - -65.44 %
Seq. Total Liabilities Change -31.12 % -0.07 % 25.79 % 1.51 % -13.95 %



Tangible Leverage Ratio third quarter 2018 Comment
Despite repayements of liabilities of -31.12%, in III. Quarter ,Tangible Leverage Ratio detoriated to 17.02, a new company high.

Within Biotechnology & Drugs industry in the third quarter 2018, 133 other companies have achieved lower Tangible Leverage Ratio than Mateon Therapeutics Inc. While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is OXGN Market Share?
Tangible Leverage Ratio third quarter 2018 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 134
Healthcare Sector # 569
Overall Market # 3701


Tangible Leverage Ratio Statistics
High Average Low
17.02 0.9 0.02
(Sep 30 2018)   (Mar 31 2015)




Financial Statements
Mateon Therapeutics Inc's Tangible Equity $ 0 Millions Visit OXGN's Balance sheet
Mateon Therapeutics Inc's Total Liabilities $ 1 Millions Visit OXGN's Balance sheet
Source of OXGN's Sales Visit OXGN's Sales by Geography




Companies with similar Tangible Leverage Ratio in the quarter endingSep 30 2018, within Biotechnology & Drugs Industry Tangible Leverage RatioSep 30 2018 MRQ Total LiabilitiesSep 30 2018 MRQ Tangible Equity
Intelgenx Technologies Corp.  23.66 $ 10.599  Millions$ 0.448  Millions
Mateon Therapeutics Inc  17.02 $ 0.987  Millions$ 0.058  Millions
Coherus Biosciences, Inc.  14.62 $ 129.068  Millions$ 8.831  Millions
Gilead Sciences Inc  14.36 $ 36,988.000  Millions$ 2,576.000  Millions
Q Biomed Inc.  8.59 $ 0.707  Millions$ 0.082  Millions
Ctd Holdings Inc  7.66 $ 1.655  Millions$ 0.216  Millions
Navidea Biopharmaceuticals, Inc.  4.55 $ 7.163  Millions$ 1.574  Millions
Axovant Sciences Ltd.  4.14 $ 82.309  Millions$ 19.879  Millions


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

V's Profile

Stock Price

V's Financials

Business Description

Fundamentals

Charts & Quotes

V's News

Suppliers

V's Competitors

Customers & Markets

Economic Indicators

V's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071